Page last updated: 2024-08-26

imipenem, anhydrous and Urinary Tract Infections

imipenem, anhydrous has been researched along with Urinary Tract Infections in 112 studies

Research

Studies (112)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (16.96)	18.7374
1990's	24 (21.43)	18.2507
2000's	24 (21.43)	29.6817
2010's	27 (24.11)	24.3611
2020's	18 (16.07)	2.80

Authors

Authors	Studies
Hatano, K; Ikeda, F; Nakai, T; Takeda, S; Wakai, Y	1
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT	1
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K	1
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K	1
Ahmed, S; Ali, F; Andleeb, F; Gul, S; Rasheed, A; Sabir, MS; Sardar, S; Shakeela, Q; Ullah, A	1
Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B	1
Bezruk, VV; Bulyk, TS; Buriak, OH; Godovanets, OS; Honcharuk, LM; Hresko, MD; Hresko, MM; Makarova, OV; Pervozvanska, OI; Rynzhuk, LV; Sheremet, MI; Shkrobanets, ID; Velia, MI; Voytkevich, NI; Yurkiv, OI; Yurniuk, SV	1
Al Atbee, MYN; Jalil, MB	1
Baba, T; Boucher, HW; Chambers, HF; Collyar, D; Dai, W; Doernberg, SB; Evans, SR; Fowler, VG; Gelone, SP; Hamasaki, T; Hill, C; Holland, TL; Howard-Anderson, J; Kinamon, T; Mariano, D; Nambiar, S; Rubin, D	1
Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR	1
Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A	1
König, E; Zollner-Schwetz, I	1
Chang, CY; Ho, MW; Hsueh, PR; Huang, YT; Ko, WC; Lee, YL	1
Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ	1
Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z	1
Karlowsky, JA; Kazmierczak, KM; Lob, SH; Motyl, MR; Sahm, DF; Young, K	1
Asay, R; Awad, M; El Nekidy, WS; Fimognari, P; Ghazi, IM; Knarr, A	1
Kuiper, SG; Leegwater, E; van Nieuwkoop, C; Wilms, EB	1
Aoyama, N; Bando, H; Brown, M; Kawahara, K; Kikukawa, H; Kohno, S; Paschke, A; Shirakawa, M; Takase, A; Yoneyama, F	1
Duan, Q; Gu, L; Hu, F; Huang, W; Jiang, X; Kang, M; Kong, H; Liao, K; Shan, B; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, H; Yu, Y; Zhang, H; Zhang, S; Zhang, W	1
Asgarian, R; Badamchi, A; Javadinia, S; Masoumi, H; Tabatabaee, A	1
Akers, W; Brown, ML; Du, J; Kartsonis, NA; Lee, YC; Mariyanovski, V; McLeroth, P; Paschke, A; Pedley, A; Sims, M	1
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD	1
Ali, I; Shabbir, M	1
Bhattacharjee, A; Deshamukhya, C; Gajamer, VR; Paul, D; Pradhan, N; Singh, AK; Tiwari, HK	1
Badal, R; Duan, Q; Gui, B; Huang, W; Jiang, X; Kong, H; Li, H; Liao, K; Ni, Y; Shan, B; Sun, Z; Wang, W; Wang, Y; Wu, A; Xu, Y; Yang, C; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Gong, S; Hu, X; Jiang, Y; Li, J; Shang, X; Yu, R; Zhang, X; Zhang, Y	1
Baillon-Plot, N; Charbonneau, C; Di Virgilio, R; Falcone, M; Kongnakorn, T; Tichy, E; Wagenlehner, F	1
Kaniga, K; Lee, M; Redman, R; Rice, DA	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ	1
Kurtinecz, M; Li, G; Mitrani-Gold, FS; Mundy, LM; Singh, KP; Tomayko, JF; Wetherington, J	1
Chau, F; Couffignal, C; Fantin, B; Lepeule, R; Massias, L; Mentre, F; Rossi, B; Ruppé, E; Soubirou, JF	1
Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M	1
Chau, F; Dion, S; Fantin, B; Lefort, A; Lepeule, R; Massias, L; Rossi, B; Soubirou, JF	1
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S	1
George, GM; Ninan, J	1
Ak, S; Ay Altıntop, Y; Balcı, PÖ; Budak, EE; Çalışkan, A; Çizmeci, Z; Çopur Çiçek, A; Fırat, M; Özgümüş, OB; Sancaktar, M; Sandallı, C; Sarı, F; Şay Coşkun, SU; Yağmur, G; Yıldız, N	1
Ciszek, M; Dobrzaniecka, K; Grochowiecki, T; Grygiel, K; Młynarczyk, G; Pączek, L; Sańko-Resmer, J; Wilkowski, P; Łabuś, A	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P	1
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V	1
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF	1
Huang, A; Huang, W; Jia, B; Li, C; Lu, P; Wu, G; Zhang, G; Zhang, W; Zhou, X	1
Ko, KS; Lee, H; Peck, KR; Song, JH	1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E	1
Ko, KS; Lee, JY	1
Fallah, F; Goudarzi, M; Jahromi, MH; Karimi, A; Navidinia, M; Sajadi Nia, RS; Shiva, F	1
Duttaroy, DD; González Patzán, LD; Kreidly, Z; Lipka, J; Sable, C; Stricklin, D; Vazquez, JA	1
Deguchi, T; Ishihara, S; Ito, M; Kawada, Y; Nakano, M; Yamada, T; Yasuda, M; Yokoi, S	1
Chen, Y; Gu, J; Hou, F; Huo, L; Jia, C; Li, J; Ren, S; Tian, X; Wang, H; Wu, G; Xue, X; Yin, Y; Zheng, B	1
Maharwal, S; Sharma, M; Taneja, N	1
Hoshinaga, K; Ishikawa, K; Miyakawa, S; Naide, Y; Shiroki, R; Tanaka, T	1
Fernández-Sampedro, M; Fernández-Torre, JL; Gutiérrez, R; Velasco, M	1
Fujita, K; Honda, Y; Kurihara, T; Ohba, H; Okimoto, N	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Avilova, ND; Gordeev, IuN; Mitrokhin, SD; Sokolov, AA; Zabaznyĭ, NP	1
Abdalhamid, B; Fabian, D; Farajallah, A; Hanson, ND; Hong, T; Levine, J; Moland, ES; Sloan, C; Thomson, KS; Wang, J	1
Angio, LG; D'Ambrosio, FP; Tigano, F	1
Gandolfi, P; Goldoni, S; Lancione, P; Miano, L; Tubaro, A; Vicentini, C	1
Bethimouti, K; Ikonomidis, A; Kondyli, L; Legakis, NJ; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A	1
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H	1
An, HG; Jeon, SS; Kang, IS; Yu, SM	1
Antón-Aranda, E; Martí Cabané, J	1
Ikonomidis, A; Markou, F; Poulou, A; Pournaras, S; Spanakis, N; Tsakris, A	1
Melzer, M; Petersen, I	1
Arora Ray, S; Bal, M; Saha, S	1
Actis, LA; Cisneros, JM; Fernández-Cuenca, F; Martí, S; Martínez-Martínez, L; McQueary, C; Pachón, J; Pascual, A; Rodríguez-Baño, J; Soto, S; Vila, J	1
Neu, HC	1
Cox, CE; Geckler, RW; Holloway, WJ	1
Kuijper, EJ; Prins, JM; Speelman, P; van Agtmael, MA; van Deventer, SJ	1
Chimura, T; Matsuo, M; Ogawa, T; Yokoyama, Y	1
Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O	1
Endoh, K; Goto, H; Igarashi, H; Kawahara, M; Kiyota, H; Machida, T; Mitani, H; Onodera, S; Suzuki, H; Takamizawa, S	1
Cravarezza, P; Romanelli, G	1
Baldassarre, R; Comunale, L; Poletti, G; Tallarigo, C	1
Kumazawa, J; Matsumoto, T; Nagayama, A	1
Colardyn, F; Faulkner, KL	1
Okonogi, K; Tsuchimori, N; Yamazaki, T	1
Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H	1
Hostacká, A	1
Eltahawy, AT	1
Hashiguchi, J; Hayashi, M; Hori, T; Hoshino, K; Iwasaki, S; Kiyokawa, S; Maeda, K; Maruta, N; Matsuo, R; Morimitsu, H; Nishimura, N; Saito, Y; Shimomae, H; Shindo, K; Suzu, H; Taide, M; Yamada, J	1
Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME	1
Half, E; Lidar, M; Rachmani, R; Ravid, M	1
Blondeau, JM; Suter, M; Vaughan, D; Yaschuk, Y	1
Cardoso, O; Leitão, R; Peixe, L; Sousa, JC	1
Chambers, H; Horn, D; Lemke, J; Luchi, M; Morrison, DC; Opal, S; Ryan, JL; Slotman, G; Wiesenfeld, H; Yoneda, K	1
Hou, F; Wu, G; Zheng, B	1
Naber, KG; Salmen, HC; Savov, O	1
Nagayama, A; Nomura, S	1
Kuroe, K; Nakaji, S; Ogasawara, H; Saito, S; Sakata, Y; Sawada, Y; Shinagawa, H; Soma, N; Takami, H; Tsushima, K	1
Ikeuchi, T; Kai, Y; Yogi, S; Yoshikawa, H	1
Kobayashi, N; Masuda, H; Nagamatsu, H; Negishi, T; Saitoh, H; Takeuchi, S; Tohsaka, A; Uchijima, Y; Yamada, T; Yoshida, K	1
Calandra, GB; Garau, J	1
Norrby, SR	1
Antonucci, G; Armignacco, O; Bordi, E; Bove, G; D'Amato, C; De Carli, G; De Mori, P; Rosci, MA; Visco, G	1
Adam, D; Bauernfeind, A; Hönig, E; Naber, KG	1
Asano, H; Fujita, T; Hirabayashi, S; Ishiguro, K; Naide, Y; Ogawa, T; Suzuki, K; Takanashi, K; Tamai, H; Yanaoka, M	1
Hayasaki, M; Ito, K; Izumi, K; Takagi, H; Tamaya, T	1
Jones, SR; Kimbrough, R	1
Goto, T; Hanabusa, A; Imamura, A; Kawabata, T; Kawahara, M; Nagata, S; Ohi, Y; Sakamoto, N; Shimada, T; Yanase, I	1
Fujita, K; Inyaku, F; Kakehashi, H; Maruyama, S; Murono, K; Ohmi, H; Sakata, H; Sanae, N; Yoshioka, H	1
Hirosawa, H; Hoshina, H; Ichihashi, H; Morikawa, Y	1
Bouza, E; Garau, J; García Rodríguez, JA; Gobernado, M; Martín, R; Martínez Luengas, F; Montero, R; Perea, E; Romero, J	1
Adam, D; Bauernfeind, A; Hönig, E; Naber, K; Tiebel, R	1
Satoh, K; Watanabe, A	1
Hollandt, H; Schier, H; Valesky, A; Wenk, H	1
Bremner, DA; Downey, D; Ellis-Pegler, RB	1
Hilton, E; Iannini, GM; Iannini, PB; Kunkel, MJ	1
Corrado, ML; Cox, CE	1
Donabedian, H; Freimer, EH; Raeder, R; Ribner, BS	1
Brown, KR; Calandra, GB; Hesney, M	1

Reviews

6 review(s) available for imipenem, anhydrous and Urinary Tract Infections

Article	Year
Treatment options for multidrug-resistant Gram-negatives in urinary tract infections. Current opinion in urology, 2023, 05-01, Volume: 33, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacterial Infections; Humans; Imipenem; Urinary Tract Infections	2023
Evaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:15 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2020
Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Databases, Bibliographic; Doripenem; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Male; Research Design; Treatment Outcome; Urinary Tract Infections	2013
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1995, Volume: 47, Issue:3 Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections	1995
UTIs and two new antibiotics in the elderly. Geriatrics, 1988, Volume: 43, Issue:7 Topics: Aged; Anti-Bacterial Agents; Aztreonam; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Thienamycins; Urinary Tract Infections	1988

Trials

23 trial(s) available for imipenem, anhydrous and Urinary Tract Infections

Article	Year
The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin; Cilastatin, Imipenem Drug Combination; Humans; Imipenem; Intraabdominal Infections; Japan; Urinary Tract Infections	2021
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections. The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Pyelonephritis; Urinary Tract Infections; Young Adult	2017
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials. International journal of antimicrobial agents, 2013, Volume: 41, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections	2013
A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections. Chemotherapy, 2010, Volume: 56, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Hospitals, Teaching; Humans; Imipenem; Male; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections; Young Adult	2010
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study. Current medical research and opinion, 2012, Volume: 28, Issue:12 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cilastatin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyelonephritis; Urinary Tract Infections	2012
A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. Chinese medical journal, 2002, Volume: 115, Issue:12 Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cilastatin; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	2002
A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:1 Topics: Bacteria; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Protease Inhibitors; Thienamycins; Urinary Tract Infections	1995
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. The Journal of infectious diseases, 1995, Volume: 172, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Ceftazidime; Double-Blind Method; Endotoxins; Enterobacter cloacae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Interleukin-8; Klebsiella pneumoniae; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Tumor Necrosis Factor-alpha; Urinary Tract Infections	1995
[Clinical effects of imipenem/cilastatin sodium on gynecological infections]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:8 Topics: Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Imipenem; Japan; Urinary Tract Infections	1994
Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Bacterial Infections; Carbapenems; Ceftazidime; Cilastatin; Humans; Imipenem; Injections, Intramuscular; Meropenem; Respiratory Tract Infections; Thienamycins; Treatment Outcome; Urinary Tract Infections	1995
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1995, Volume: 47, Issue:3 Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections	1995
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Hospitals; Humans; Imipenem; Infusions, Intravenous; Injections, Intravenous; Male; Meropenem; Middle Aged; Peritonitis; Protease Inhibitors; Respiratory Tract Infections; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections	1996
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin	1997
[Efficacy and safety of intramuscular imipenem/cilastatin (IPM/CS) for complicated urinary tract infections]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:7 Topics: Adolescent; Aged; Aged, 80 and over; Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Injections, Intramuscular; Male; Middle Aged; Urinary Tract Infections	1997
A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with gram-negative urosepsis. Urosepsis Study Group. Journal of endotoxin research, 2000, Volume: 6, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cytokines; Double-Blind Method; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Sepsis; Urinary Tract Infections	2000
[A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:9 Topics: Cilastatin; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Respiratory Tract Infections; Thienamycins; Treatment Outcome; Urinary Tract Infections	2001
Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pyelonephritis; Sample Size; Tazobactam; Thienamycins; Urinary Tract Infections	2002
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:8 Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Lincomycin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Pneumonia; Sepsis; Urinary Tract Infections	1992
Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience. Chemotherapy, 1991, Volume: 37 Suppl 2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Injections, Intramuscular; Male; Middle Aged; Pelvic Inflammatory Disease; Respiratory Tract Infections; Skin Diseases, Infectious; United States; Urinary Tract Infections	1991
Challenges in the design of trials to evaluate antibacterial agents in serious infections. The Journal of hospital infection, 1990, Volume: 15 Suppl A Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Europe; Female; Humans; Imipenem; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Urinary Tract Infections	1990
The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections. Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:2 Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Urinary Tract Infections	1990
Empirical use of imipenem as the sole antibiotic in the treatment of serious infections. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Urinary Tract Infections	1985
Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. Clinical therapeutics, 1985, Volume: 7, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Dipeptidases; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	1985

Other Studies

84 other study(ies) available for imipenem, anhydrous and Urinary Tract Infections

Article	Year
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Animals; beta-Lactamases; Burns; Cephalosporins; Drug Resistance, Multiple, Bacterial; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections; Wound Infection	2007
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections	2008
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections. Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Suppleme Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2021
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections	2022
Comparative in vitro activity of selected antibacterial agents against Escherichia coli isolated from hospitalized patients suffering UTI. Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Sulfamethoxazole; Tobramycin; Trimethoprim; Urinary Tract Infections	2022
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar. Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:3(Special) Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin	2022
Management of antibacterial therapy of infectious and inflammatory diseases of the urinary tract in children and regional peculiarities during the COVID-19 pandemic. Journal of medicine and life, 2022, Volume: 15, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; COVID-19 Drug Treatment; Doxycycline; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Pandemics; Urinary Tract; Urinary Tract Infections	2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Anti-Bacterial Agents; Doripenem; Humans; Imipenem; Levofloxacin; Urinary Tract Infections	2023
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic Polish journal of microbiology, 2022, Sep-01, Volume: 71, Issue:3 Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors	2022
Genotypic Detection of Archives of Razi Institute, 2022, Volume: 77, Issue:2 Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections	2022
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020. International journal of antimicrobial agents, 2023, Volume: 61, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Taiwan; Urinary Tract Infections	2023
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study. International journal of antimicrobial agents, 2023, Volume: 62, Issue:5 Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections	2023
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections	2020
In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015-2017. Journal of global antimicrobial resistance, 2020, Volume: 21 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Enterobacteriaceae; Humans; Imipenem; Pseudomonas aeruginosa; United States; Urinary Tract Infections	2020
Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach. PloS one, 2020, Volume: 15, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Drug Combinations; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections	2020
In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-23, Volume: 71, Issue:Suppl 4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; China; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Imipenem; Intraabdominal Infections; Microbial Sensitivity Tests; Respiratory System; United States; Urinary Tract Infections	2020
Molecular detection of six virulence genes in Pseudomonas aeruginosa isolates detected in children with urinary tract infection. Microbial pathogenesis, 2017, Volume: 107 Topics: ADP Ribose Transferases; Anti-Bacterial Agents; Bacterial Toxins; Cefotaxime; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Exotoxins; Genes, Bacterial; Humans; Imipenem; Iran; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Transferases (Other Substituted Phosphate Groups); Urinary Tract Infections; Virulence Factors	2017
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients. Clinical therapeutics, 2017, Volume: 39, Issue:8 Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult	2017
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups. JPMA. The Journal of the Pakistan Medical Association, 2017, Volume: 67, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult	2017
Escherichia coli encoding bla Journal of global antimicrobial resistance, 2018, Volume: 14 Topics: Adult; beta-Lactamases; Community-Acquired Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Imipenem; India; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Urinary Tract Infections; Young Adult	2018
Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC infectious diseases, 2018, Sep-29, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; China; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections	2018
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis. BioMed research international, 2019, Volume: 2019 Topics: Ertapenem; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Quinolones; Sepsis; Shock, Septic; Urinary Tract Infections	2019
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections. International journal of antimicrobial agents, 2019, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Cost-Benefit Analysis; Drug Combinations; Europe; Gram-Negative Bacteria; Humans; Imipenem; Length of Stay; National Health Programs; United States; Urinary Tract Infections	2019
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011. Clinical therapeutics, 2013, Volume: 35, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections	2013
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Treatment Outcome; Urinary Tract Infections	2015
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin	2015
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression; Humans; Imipenem; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Plasmids; Pyelonephritis; Urinary Tract Infections; Uropathogenic Escherichia coli	2016
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:4 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Imipenem-cilastatin-induced psychosis: a case report. Journal of medical case reports, 2016, Apr-27, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Middle Aged; Psychoses, Substance-Induced; Shock, Septic; Urinary Tract Infections	2016
[Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study]. Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:2 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Escherichia coli Infections; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2016
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping. Transplantation proceedings, 2016, Volume: 48, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Drug Combinations; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Genotype; Gentamicins; Humans; Imipenem; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections	2017
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics. Bosnian journal of basic medical sciences, 2009, Volume: 9, Issue:1 Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin	2009
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections	2010
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea. Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections	2011
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections	2012
OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. International journal of antimicrobial agents, 2012, Volume: 40, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Silencing; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins; Urinary Tract Infections	2012
Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections. Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:6 Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Imipenem; Integrons; Male; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Urinary Tract Infections; Uropathogenic Escherichia coli	2012
Antimicrobial activity of imipenem against isolates from complicated urinary tract infections. International journal of antimicrobial agents, 2002, Volume: 19, Issue:6 Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections	2002
Imipenem resistance in nonfermenters causing nosocomial urinary tract infections. Indian journal of medical sciences, 2003, Volume: 57, Issue:7 Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Urinary Tract Infections	2003
[The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2004, Volume: 95, Issue:1 Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefozopran; Cefpirome; Cephalosporins; Cilastatin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections	2004
Encephalopathy secondary to imipenem therapy. Clinical EEG and neuroscience, 2004, Volume: 35, Issue:2 Topics: Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Imipenem; Staphylococcal Infections; Urinary Tract Infections	2004
[A case of pseudomembranous enterocolitis caused by methicillin-resistant Staphylococcus aureus]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2004, Volume: 78, Issue:10 Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterocolitis, Pseudomembranous; Female; Humans; Imipenem; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections	2004
[Imipenem and cefepime in empirical therapy of infectious complications after radical surgeries in patients with invasive cancer of the urinary bladder]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:8-9 Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cystectomy; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasm Staging; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms; Urinary Tract Infections	2004
Escherichia coli: development of carbapenem resistance during therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-15, Volume: 40, Issue:10 Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Urinary Tract Infections	2005
A clinical study of imipenem/cilastatin in the treatment of generalized and localized infections. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Survival Analysis; Treatment Outcome; Urinary Tract Infections	1989
Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enzyme Inhibitors; Female; Humans; Imipenem; Inpatients; Male; Middle Aged; Safety; Urinary Tract Infections; Urologic Diseases	1989
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Intensive Care Units; Pneumonia, Bacterial; Urinary Tract Infections	2006
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:3 Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin	2006
[Status of nosocomial urinary tract infections in the ICU: molecular epidemiology of imipenem resistant P. aeruginosa]. Taehan Kanho Hakhoe chi, 2006, Volume: 36, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Urinary Catheterization; Urinary Tract Infections	2006
[Escherichia coli endocarditis: a report of two cases]. Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Combined Modality Therapy; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gastroenteritis; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Imipenem; Middle Aged; Urinary Tract Infections	2007
Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Conjugation, Genetic; Drug Resistance, Bacterial; Greece; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Urinary Tract Infections	2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. The Journal of infection, 2007, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections	2007
Imipenem-resistance among multi-drug resistant clinical strains in urinary infections from Kolkata. The Indian journal of medical research, 2007, Volume: 125, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Urinary Tract Infections	2007
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheters, Indwelling; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Meningitis; Middle Aged; Urinary Tract Infections	2008
Clinical perspectives on imipenem. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl D Topics: Bacteria; Bacterial Infections; Bacterial Proteins; Carrier Proteins; Hexosyltransferases; Humans; Imipenem; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Thienamycins; Urinary Tract Infections	1983
Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis. Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:8 Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Female; Imipenem; Kidney Calculi; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Bladder Calculi; Urinary Calculi; Urinary Tract Infections	1994
[Influence of urine pH and cations on antimicrobial activities of penems]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1993, Volume: 67, Issue:5 Topics: Cations, Divalent; Escherichia coli; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins; Urinary Tract Infections; Urine	1993
Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Urinary Tract Infections	1996
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3 Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections	1997
Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa. Arzneimittel-Forschung, 1997, Volume: 47, Issue:8 Topics: Carbapenems; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections	1997
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries	1997
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections	1998
Insulin autoimmune syndrome after therapy with imipenem. Diabetes care, 1999, Volume: 22, Issue:3 Topics: Aged; Autoimmune Diseases; Humans; Imipenem; Insulin; Male; Thienamycins; Urinary Tract Infections	1999
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Haemophilus; Humans; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moraxella; Pseudomonas; Respiratory Tract Infections; Staphylococcus; Streptococcus; Ticarcillin; Urinary Tract Infections	1999
Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1 Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Imipenem; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1999
In vitro antibacterial activity of S-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Ceftazidime; Doripenem; Humans; Imipenem; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Thienamycins; Urinary Tract Infections	2002
[Clinical studies of efficacy of imipenem/cilastatin sodium against urinary tract infections with ureterocutaneostomy]. Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:3 Topics: Adult; Aged; Cilastatin; Dermatologic Surgical Procedures; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Postoperative Complications; Ureterostomy; Urinary Tract Infections	1992
[Efficacy of sodium imipenem/cilastatin on patients of complicated urinary tract infections--following the failure of prior antimicrobial agents]. Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Humans; Imipenem; Male; Middle Aged; Urinary Tract Infections	1992
[Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections]. Infection, 1986, Volume: 14 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Humans; Imipenem; Male; Middle Aged; Premedication; Prostatic Hyperplasia; Thienamycins; Tissue Distribution; Urinary Tract Infections	1986
[A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections]. Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus; Thienamycins; Urinary Tract Infections	1986
[Fundamental and clinical evaluation of imipenem/cilastatin sodium in the perinatal period]. The Japanese journal of antibiotics, 1988, Volume: 41, Issue:11 Topics: Adult; Bacterial Infections; Chemical Phenomena; Chemistry; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Endometritis; Female; Humans; Imipenem; Infusions, Intravenous; Lactation; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Urinary Tract Infections	1988
[Bacterial and clinical studies on imipenem/cilastatin sodium in urological infection]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:4 Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Cilastatin; Cyclopropanes; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins; Urinary Tract Infections; Urine	1986
[Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in children]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:7 Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Pneumonia; Sepsis; Thienamycins; Thyroiditis; Urinary Tract Infections	1986
[Clinical evaluation of imipenem/cilastatin sodium in the pediatric field]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:7 Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Infant; Kinetics; Lymphadenitis; Male; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1986
Imipenem in the treatment of severe bacterial infections in seriously ill patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E Topics: Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Imipenem; Male; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1986
Imipenem in the treatment of complicated urinary tract infection. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Aged; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Urinary Tract Infections	1987
[A clinical study on imipenem/cilastatin sodium in the field of pediatrics]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:7 Topics: Bacterial Infections; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Escherichia coli Infections; Female; Gastroenteritis; Haemophilus Infections; Humans; Imipenem; Infant; Male; Neisseria; Respiratory Tract Infections; Streptococcal Infections; Thienamycins; Urinary Tract Infections	1986
[Imipenem/cilastatin in surgical intensive medicine]. Infection, 1986, Volume: 14 Suppl 2 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1986
Early clinical experience with imipenem-cilistatin. The New Zealand medical journal, 1985, Mar-27, Volume: 98, Issue:775 Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1985
Imipenem/cilastatin: general experience in a community hospital. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Drug Combinations; Female; Hospitals, Community; Humans; Imipenem; Male; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1985
Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Adult; Aged; Cilastatin; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins; Urinary Tract Infections	1985